- Launay, Nathalie
- Ruiz, Montserrat
- Planas-Serra, Laura
- Verdura, Edgard
- Rodríguez-Palmero, Agustí
- Schlüter, Agatha
- Goicoechea, Leire
- Guilera, Cristina
- Casas, Josefina
- Campelo, Felix
- Jouanguy, Emmanuelle
- Casanova, Jean-Laurent
- Boespflug-Tanguy, Odile
- Vazquez Cancela, Maria
- Gutiérrez-Solana, Luis González
- Casasnovas, Carlos
- Area-Gomez, Estela
- Pujol, Aurora
The Rad50 interacting protein 1 (Rint1) is a key player in vesicular trafficking between the ER and Golgi apparatus. Biallelic variants in RINT1 cause infantile-onset episodic acute liver failure (ALF). Here, we describe 3 individuals from 2 unrelated families with novel biallelic RINT1 loss-of-function variants who presented with early onset spastic paraplegia, ataxia, optic nerve hypoplasia, and dysmorphic features, broadening the previously described phenotype. Our functional and lipidomic analyses provided evidence that pathogenic RINT1 variants induce defective lipid-droplet biogenesis and profound lipid abnormalities in fibroblasts and plasma that impact both neutral lipid and phospholipid metabolism, including decreased triglycerides and diglycerides, phosphatidylcholine/phosphatidylserine ratios, and inhibited Lands cycle. Further, RINT1 mutations induced intracellular ROS production and reduced ATP synthesis, affecting mitochondria with membrane depolarization, aberrant cristae ultrastructure, and increased fission. Altogether, our results highlighted the pivotal role of RINT1 in lipid metabolism and mitochondria function, with a profound effect in central nervous system development., We are indebted to the patients and families who participated in this study. We thank Veronica Villagrasa Araya and Juanjo Martínez for their excellent technical assistance. We thank Saioa Mendizuri and Joan Repullés from the IDIBELL Optical Microscopy Platform and Cristina Pardo from the IDIBELL Electron Microscopy Platform for their help and excellent suggestions. This study was supported by the Centre for Biomedical Research on Rare Diseases (CIBERER) (ACCI19-759), the URDCat programme (PERIS SLT002/16/00174), the Hesperia Foundation and the Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia (2017SGR1206), and the Association ASL-HSP to AP. This study was also funded by the Instituto de Salud Carlos III and ‘Fondo Europeo de Desarrollo Regional (FEDER), Unión Europea, una manera de hacer Europa’ (FIS PI20/00758) to CC and ‘La Marató de TV3’ Foundation (202006-30) to CC and AP. NL and MR are supported by the Center for Biomedical Research on Rare Diseases (CIBERER). EV was supported by a Sara Borrell postdoctoral contract granted by the Instituto de Salud Carlos III through grant CD19/00221 (cofunded by the European Social Fund, ESF). FC is supported by Government of Spain (RYC-2017-22227, PID2019-106232RB-I00/10.13039/501100011033; Severo Ochoa CEX2019-000910-S), Fundació Cellex, Fundació Mir-Puig. JC is supported by La Marató de TV3’ Foundation (202006-31). We thank the CERCA Program/Generalitat de Catalunya for institutional support., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2019-000910-S)., Peer reviewed